Find uplifting stories about heroes, innovations, and solutions
52 results for "semaglutide"
Millions who avoid needles can now access a breakthrough weight loss medication in pill form. The FDA just approved oral semaglutide and a higher-dose option, making effective obesity treatment easier than ever.
A breakthrough study of 95,000 patients found that semaglutide, the active ingredient in Ozempic and Wegovy, significantly reduces the risk of worsening mental health in people with diabetes and depression. The discovery could offer hope for millions living with both conditions.
A major new study brings surprising good news for people taking the diabetes medication semaglutide (Ozempic). Despite losing more weight than users of other medications, they experienced 15% fewer bone fractures.
A diabetes medication known for weight loss is proving to be a powerful ally for kidney and heart health. New research shows semaglutide can slow kidney disease progression and save lives.
Semaglutide, the active ingredient in Ozempic and Wegovy, helped people with obesity reduce heavy drinking days by 41% in a groundbreaking six-month trial. This marks the first randomized study testing GLP-1 drugs for alcohol use disorder treatment.
A daily pill form of semaglutide (the drug in Ozempic) helped people with alcohol use disorder drink less heavily in a University of Colorado trial. The breakthrough suggests these medications could offer new hope for treating addiction beyond their current uses.
More people with obesity are getting treatment now than at any point in the past 20 years, thanks to breakthrough medications like semaglutide. A major study tracking over 200,000 patients shows how policy changes and new drugs transformed access to life-changing care.
Brazil just approved a new semaglutide treatment that could help 16.5 million people with diabetes access life-changing medication. The affordable option launches later this year, with the potential to reach millions who currently go undiagnosed or untreated.
Scientists discovered that semaglutide, the drug behind Ozempic and Wegovy, can rebuild damaged cartilage in people with arthritis even without weight loss. The breakthrough hints at a powerful new treatment for millions suffering from joint pain.
A groundbreaking trial found that semaglutide, the popular weight loss drug, significantly reduced alcohol cravings and heavy drinking days in people battling both obesity and alcohol addiction. The discovery could transform treatment options for millions worldwide struggling with alcohol use disorder.
A breakthrough study shows the diabetes drug semaglutide helps older adults lose significant weight safely while improving heart health. Nearly half of participants over 65 achieved at least 15% weight loss in just over a year.
The diabetes and weight-loss medication semaglutide (Ozempic/Wegovy) just proved effective at treating alcohol-use disorder in a major clinical trial. Millions struggling with problem drinking now have a new treatment option their doctors already know how to prescribe.
Weight loss drug semaglutide shows unexpected mental health benefits in 100,000-person study. Depression, anxiety, and addiction rates plummeted during treatment periods.
A clinical trial shows semaglutide, the drug in Ozempic and Wegovy, slowed biological aging markers by 9% in just 32 weeks. Scientists say it's the first randomized evidence that a widely available medication may slow cellular aging processes.
The Department of Veterans Affairs is launching a major study to see if semaglutide, the ingredient in Ozempic and Wegovy, can help veterans overcome alcohol addiction. Early research suggests the diabetes and weight-loss drug may reduce cravings and drinking just like it quiets "food noise" for people with obesity.
Scientists discovered common drugs, including semaglutide, work better than current treatments at protecting brains during deadly TB meningitis infections. The breakthrough could help survivors avoid lasting brain damage.
Danish researchers found that popular GLP-1 drugs like semaglutide reduced asthma flare-ups by a quarter and cut inhaler dependence by 14%. The breakthrough suggests these medications do more than just help with weight loss.
New research reveals genetic variants that explain why weight-loss drugs like semaglutide help some people lose 25% of their body weight while others see minimal results. The discovery could pave the way for more personalized treatments.
The Department of Veterans Affairs is launching a groundbreaking trial to test whether semaglutide, a drug already used for diabetes and weight loss, can help veterans overcome alcohol addiction. More than 600 veterans at 18 medical centers will participate in the study that could unlock a new path to recovery for thousands struggling with substance abuse.
Researchers have created the first sex-specific brain map showing where popular weight-loss drugs like semaglutide work differently in females versus males. This breakthrough could explain why women often respond better to these treatments and pave the way for more personalized medicine.
Showing 20 of 52